Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Vorapaxar (brand name Zontivity, formerly known as SCH 530348) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine, discovered by Schering-Plough and developed by Merck & Co.
The analysis highlights History, Applications and Products as prominent areas in the source structure around Vorapaxar.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around Vorapaxar shows recurring relationship patterns in the source. For example, Vorapaxar → ADP, Among, FDA, February, In January, January, May, Merck, PAD, The TRA, TIMI Another extracted example is Vorapaxar → CYP3A, CYP3A4, John's, St. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
stroke risk bleeding history heart attack patients coronary death cyp3a4 antagonist persons cardiovascular intracranial par-1 revascularization drug dose adjustment hepatic
TTTA extracted 46 structured relationships around Vorapaxar. Examples in this analysis include Vorapaxar → 3D model (JSmol) → Interactive image and Vorapaxar → ATC code → B01AC26 (WHO). The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Vorapaxar | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Vorapaxar | ATC code | B01AC26 (WHO) | 1.00 | infobox |
| Vorapaxar | Bioavailability | ~100% | 1.00 | infobox |
| Vorapaxar | CAS Number | 618385-01-6 Y | 1.00 | infobox |
| Vorapaxar | ChEBI | CHEBI:82702 N | 1.00 | infobox |
| Vorapaxar | ChEMBL | ChEMBL493982 N | 1.00 | infobox |
| Vorapaxar | ChemSpider | 8252668 N | 1.00 | infobox |
| Vorapaxar | CompTox Dashboard (EPA) | DTXSID201009336 | 1.00 | infobox |
| Vorapaxar | ECHA InfoCard | 100.116.767 | 1.00 | infobox |
| Vorapaxar | Elimination half-life | 5–13 days | 1.00 | infobox |
| Vorapaxar | Excretion | feces (58%), urine (25%) | 1.00 | infobox |
| Vorapaxar | Formula | C29H33FN2O4 | 1.00 | infobox |
| Vorapaxar | IUPHAR/BPS | 4047 | 1.00 | infobox |
| Vorapaxar | Legal status | CA: ℞-only | 1.00 | infobox |
| Vorapaxar | Legal status | US: ℞-only | 1.00 | infobox |
| Vorapaxar | Melting point | 278 °C (532 °F) | 1.00 | infobox |
| Vorapaxar | Metabolism | hepatic (CYP3A4 and CYP2J2) | 1.00 | infobox |
| Vorapaxar | Molar mass | 492.591 g·mol−1 | 1.00 | infobox |
| Vorapaxar | Other names | SCH-530348 | 1.00 | infobox |
| Vorapaxar | Protein binding | ≥99% | 1.00 | infobox |
| Vorapaxar | PubChem CID | 10077130 | 1.00 | infobox |
| Vorapaxar | Routes of administration | By mouth | 1.00 | infobox |
| Vorapaxar | Trade names | Zontivity | 1.00 | infobox |
| Vorapaxar | UNII | ZCE93644N2 | 1.00 | infobox |
The concept neighborhoods around Vorapaxar bring nearby vocabulary together. In this analysis, examples include Attack, Stroke and Heart. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Vorapaxar, one of the stronger structural bridges in this analysis connects Vorapaxar with Drug interactions. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Vorapaxar to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Applications & Products, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Vorapaxar · EN edition · Analysis: TopicsToTalkAbout